Key takeaways from week 7 of the Elizabeth Holmes trial. – .

Key takeaways from week 7 of the Elizabeth Holmes trial. – .

Prosecutors said this was still misleading, as the line said Theranos’ use of venous prints was “rare.” Previous testimonials have shown that Theranos used venous pulls in about 40% of its tests for Walgreens.

To convict Ms Holmes, the government will have to prove that she – and not Sunny Balwani, the former COO of Theranos and her ex-boyfriend – was the one in command.

Their relationship is essential. Ms Holmes’ attorneys have said in the documents that they could argue that Mr Balwani abused Ms Holmes. Mr. Balwani, who faces a separate trial next year, has denied the allegations.

This week, Mr. Edlin testified that he saw Mr. Balwani defer to Ms. Holmes in the event of a disagreement.

“Usually she was the CEO, so she had the final decision-making power,” he said.

Due to his friendship with Ms Holmes’ brother, Mr Edlin was also aware of Ms Holmes and Mr Balwani’s romantic relationship, which they kept a secret. Ms Holmes and Mr Balwani were “much more relaxed” and “social” outside of work hours, but “nothing special” stood out about their dynamic, Mr Edlin said.

On Friday, prosecutors presented a key point raised at the start of the trial.

Shane Weber, a scientist from Pfizer, said that after reviewing data from Theranos and interviewing Ms Holmes in 2008, he was not impressed. In emails presented as evidence, Mr. Weber wrote to colleagues that the conclusions in Theranos’ reports were “not credible” and that the company’s responses to the questions were “uninformative, tangential, roundabout or evasive” . He recommended that Pfizer not work with Theranos.


Please enter your comment!
Please enter your name here